•A unique genetic alteration drives the pathogenesis of fibrolamellar carcinoma (DNAJB1-PRKCA fusion) and hepatic haemangioendothelioma (CAMTA1-WWTR1 fusion). Here, PRKCA is linked to fibrolamellar hepatocellular carcinoma.